- Home
- CEAD vs PPBT Comparison
CEAD vs PPBT Comparison
Compare CEAD & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- PPBT
- Stock Information
- Founded
- CEAD 2009
- PPBT 2010
- Country
- CEAD United States
- PPBT Israel
- Employees
- CEAD N/A
- PPBT N/A
- Industry
- CEAD Industrial Machinery/Components
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- PPBT Health Care
- Exchange
- CEAD Nasdaq
- PPBT Nasdaq
- Market Cap
- CEAD 6.9M
- PPBT 7.1M
- IPO Year
- CEAD N/A
- PPBT N/A
- Fundamental
- Price
- CEAD $8.46
- PPBT $2.68
- Analyst Decision
- CEAD
- PPBT Strong Buy
- Analyst Count
- CEAD 0
- PPBT 1
- Target Price
- CEAD N/A
- PPBT $33.00
- AVG Volume (30 Days)
- CEAD 22.9K
- PPBT 10.3K
- Earning Date
- CEAD 03-27-2025
- PPBT 03-10-2025
- Dividend Yield
- CEAD N/A
- PPBT N/A
- EPS Growth
- CEAD N/A
- PPBT N/A
- EPS
- CEAD N/A
- PPBT N/A
- Revenue
- CEAD $2,803,470.00
- PPBT N/A
- Revenue This Year
- CEAD N/A
- PPBT N/A
- Revenue Next Year
- CEAD N/A
- PPBT N/A
- P/E Ratio
- CEAD N/A
- PPBT N/A
- Revenue Growth
- CEAD N/A
- PPBT N/A
- 52 Week Low
- CEAD $5.60
- PPBT $2.00
- 52 Week High
- CEAD $12.26
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- CEAD 49.33
- PPBT 42.85
- Support Level
- CEAD $7.90
- PPBT $2.64
- Resistance Level
- CEAD $9.45
- PPBT $2.93
- Average True Range (ATR)
- CEAD 0.86
- PPBT 0.15
- MACD
- CEAD 0.06
- PPBT 0.01
- Stochastic Oscillator
- CEAD 63.44
- PPBT 10.15
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.